No connection

Search Results

AKO-B

NEUTRAL
$30.75 Live
Embotelladora Andina S.A. · NYSE
Target $30.88 (+0.4%)
$17.9 52W Range $31.43

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
$4.85B
P/E
16.44
ROE
24.7%
Profit margin
7.9%
Debt/Equity
1.01
Dividend yield
4.41%

AI Analysis

AI-powered fundamental assessment

Confidence
72%
The Advanced Deterministic Scorecard reveals a deeply concerning Piotroski F-Score of 0/9, indicating severe financial health weaknesses, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite this, the company demonstrates strong profitability with a 24.73% ROE and solid 36.3% YoY earnings growth, supported by a robust 4.41% dividend yield and 70% dividend strength. Valuation appears mixed: trading at a P/E of 16.44 below sector average, yet far above the Graham Number of $224.66 when adjusted for currency context, suggesting potential overvaluation. Technical trend is weak at 10/100, and insider sentiment is lukewarm, offsetting strong recent price performance (+67.2% 1Y).

Key Strengths

Strong return on equity (24.73%) well above sector average (4.12%)
High dividend yield of 4.41% with disciplined payout ratio (70.58%)
Solid gross margin (39.24%) indicating pricing power or cost control
Revenue and earnings growing robustly (10.1% and 36.3% YoY, respectively)
P/E ratio (16.44) below sector average (32.63), suggesting relative value

Key Risks

Critically low Piotroski F-Score of 0/9 signals severe financial statement weaknesses
Operating margin at 0.00% raises concerns about core profitability sustainability
Price/Book ratio of 0.03 is abnormally low, potentially indicating asset overstatement or hidden liabilities
Missing key financial data (EV, debt, cash, ROIC) limits full health assessment
Technical trend is deeply bearish (10/100), suggesting weakening momentum
AI Fair Value Estimate
Based on comprehensive analysis
$224.66
+630.6% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
59
Moderate
Value
62
Future
70
Past
65
Health
20
Dividend
80
AI Verdict
Neutral with significant health concerns
Key drivers: High profitability and growth offset by critical financial health red flags, Dividend strength supports investor appeal despite weak technicals, Valuation appears mixed due to conflicting Graham vs. market price signals
Confidence
75%
Value
62/100

Ref P/E, PEG, Graham Number

Positives
  • P/E of 16.44 below sector average of 32.63
  • Forward P/E of 18.41 still reasonable for growth
Watchpoints
  • Price/Book of 0.03 is alarmingly low
  • Current price ($30.75) significantly above Graham Number ($224.66) — potential unit discrepancy suggests misreporting or currency confusion
Future
70/100

Ref Growth rates

Positives
  • 36.3% YoY earnings growth
  • 53.6% Q/Q EPS growth indicates accelerating earnings
Watchpoints
  • Forward P/E rising to 18.41 may limit multiple expansion
  • No PEG ratio due to missing growth-adjusted valuation
Past
65/100

Ref Historical trends

Positives
  • 5-Year price return of +198.5% shows strong long-term appreciation
  • Consistent earnings beats in recent quarters (3 of last 4)
Watchpoints
  • High earnings volatility (e.g., -84.5% surprise in 2020-07)
  • Several large negative earnings surprises in prior years
Health
20/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Current ratio of 1.37 indicates short-term liquidity
  • Debt/Equity of 1.01 is manageable, below sector average of 1.89
Watchpoints
  • Piotroski F-Score of 0/9 indicates systemic financial weakness
  • Operating margin at 0.00% suggests no core operational profitability
  • Missing Altman Z-Score and key cash/debt data limits confidence
Dividend
80/100

Ref Yield, Payout

Positives
  • Dividend yield of 4.41% is attractive
  • Payout ratio of 70.58% is sustainable for mature firms
  • Dividend strength rated 70/100
Watchpoints
  • No 5-year average yield to assess consistency

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$30.75
Analyst Target
$30.88
Upside/Downside
+0.4%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for AKO-B and closest competitors.

Updated 2026-01-23
AKO
Embotelladora Andina S.A.
Primary
5Y
+198.5%
3Y
+156.0%
1Y
+67.2%
6M
+38.1%
1M
+12.6%
1W
+2.4%
LAU
Laureate Education, Inc.
Peer
5Y
+434.7%
3Y
+200.8%
1Y
+73.1%
6M
+14.0%
1M
-1.2%
1W
-1.9%
LOP
Grand Canyon Education, Inc.
Peer
5Y
+48.4%
3Y
+38.4%
1Y
-4.8%
6M
-20.2%
1M
+1.1%
1W
-4.0%
ATG
Adtalem Global Education Inc.
Peer
5Y
+211.0%
3Y
+215.3%
1Y
+20.9%
6M
+5.3%
1M
+17.0%
1W
+3.8%
AKO
Embotelladora Andina S.A.
Peer
5Y
+189.5%
3Y
+160.4%
1Y
+65.7%
6M
+30.5%
1M
+7.4%
1W
+4.3%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
16.44
Forward P/E
18.41
PEG Ratio
N/A
P/B Ratio
0.03
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
$4.85B

Profitability

Profit margins and return metrics

Profit Margin 7.87%
Operating Margin N/A
Gross Margin 39.23%
ROE 24.73%
ROA 8.27%

Growth

Revenue and earnings growth rates

Revenue Growth +10.1%
Earnings Growth +36.3%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth +36.3%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
1.01
Moderate
Current Ratio
1.37
Good
Quick Ratio
0.87
Poor
Cash/Share
$N/A

Quarterly Earnings History

EPS performance vs analyst estimates

2026-01-27
$N/A
2025-10-29
$362.4
+18.5% surprise
2025-07-30
$236.0
-2.6% surprise
2025-04-30
$502.1
+10.4% surprise

Consumer Defensive Sector Comparison

Comparing AKO-B against 103 companies in the Consumer Defensive sector (5 bullish, 43 neutral, 55 bearish)
P/E Ratio
16.44
This Stock
vs
31.13
Sector Avg
-47.2% (Discount)
Return on Equity (ROE)
24.73%
This Stock
vs
-21.26%
Sector Avg
-216.3% (Below Avg)
Profit Margin
7.87%
This Stock
vs
-6.73%
Sector Avg
-216.9% (Weaker)
Debt to Equity
1.01
This Stock
vs
1.57
Sector Avg
-35.7% (Less Debt)
Revenue Growth
10.1%
This Stock
vs
181.5%
Sector Avg
-94.4% (Slower)
Current Ratio
1.37
This Stock
vs
2.26
Sector Avg
-39.4% (Weaker)

Similar Companies

Peer comparison within the same industry

Past News Coverage

Recent headlines mentioning AKO-B from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile